Tiemo Wölken

Rule Changes

As of May 2026: Key Parliament architect of the final compromise on incentives and access

After two years of trench warfare between EU governments, lawmakers and drug makers, Brussels has finally agreed a 'pharma package' that tears up the bloc's 20‑year‑old drug rules. The package locks in eight years of data protection, one year of market exclusivity, and bonuses extending to 11 years if companies meet public‑health goals.

Updated May 11